Primer: Cadrenal Therapeutics (CVKD US) - Aug 2026
Cadrenal Therapeutics is a clinical-stage biopharmaceutical company focused on developing tecarfarin, a novel anticoagulant for high-risk...
101 Views
𝛼SK or SearchENTITY
Cadrenal Therapeutics (CVKD US)
Cadrenal Therapeutics (CVKD US)
14
Analysis
Health Care • United States
Cadrenal Therapeutics, Inc. operates as a biotech company. The Company focuses on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease, or ESRD, and atrial fibrillation. Cadrenal Therapeutics serves customers worldwide.
morex